Cargando…

Chronic glucolipotoxic conditions in pancreatic islets impair insulin secretion due to dysregulated calcium dynamics, glucose responsiveness and mitochondrial activity

BACKGROUND: In the progression towards diabetes, glucolipotoxicity is one of the main causes of pancreatic beta cell pathology. The aim of this study was to examine the in vitro effects of chronic glucolipotoxic conditions on cellular responses in pancreatic islets, including glucose and fat metabol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Somesh, Baggavalli P, Verma, Mahesh Kumar, Sadasivuni, Manoj Kumar, Mammen-Oommen, Anup, Biswas, Sanghamitra, Shilpa, Pavagada C, Reddy, Ashok Kumar, Yateesh, Aggunda N, Pallavi, Puttrevana M, Nethra, Siddaraju, Smitha, Rachapalli, Neelima, Korrapati, Narayanan, Usha, Jagannath, Madanahalli R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3704974/ https://www.ncbi.nlm.nih.gov/pubmed/23815372 http://dx.doi.org/10.1186/1471-2121-14-31

Ejemplares similares

Integrated analysis of chronic lipotoxicity on muscle metabolism and stress and its reversal by antioxidants
por: Verma, Mahesh Kumar, et al.
Publicado: (2014)

Activation of GPR40 attenuates chronic inflammation induced impact on pancreatic β-cells health and function
por: Verma, Mahesh Kumar, et al.
Publicado: (2014)

A novel GPR40 agonist, CNX-011-67, suppresses glucagon secretion in pancreatic islets under chronic glucolipotoxic conditions in vitro
por: Verma, Mahesh Kumar, et al.
Publicado: (2014)

Inhibition of neutral sphingomyelinases in skeletal muscle attenuates fatty-acid induced defects in metabolism and stress
por: Verma, Mahesh Kumar, et al.
Publicado: (2014)

Treatment with CNX-011-67, a novel GPR40 agonist, delays onset and progression of diabetes and improves beta cell preservation and function in male ZDF rats
por: Gowda, Nagesh, et al.
Publicado: (2013)

CNX-011-67, a novel GPR40 agonist, enhances glucose responsiveness, insulin secretion and islet insulin content in n-STZ rats and in islets from type 2 diabetic patients
por: Sunil, Venkategowda, et al.
Publicado: (2014)

CNX-013-B2, a unique pan tissue acting rexinoid, modulates several nuclear receptors and controls multiple risk factors of the metabolic syndrome without risk of hypertriglyceridemia, hepatomegaly and body weight gain in animal models
por: Sadasivuni, Manoj Kumar, et al.
Publicado: (2014)

Developing an in vitro screening assay platform for evaluation of antifibrotic drugs using precision-cut liver slices
por: Sadasivan, Satish Kumar, et al.
Publicado: (2014)

Modulation of de novo purine biosynthesis leads to activation of AMPK and results in improved glucose handling and insulin sensitivity
por: Sadasivan, Satish Kumar, et al.
Publicado: (2014)

A novel 11β-hydroxysteroid dehydrogenase type1 inhibitor CNX-010-49 improves hyperglycemia, lipid profile and reduces body weight in diet induced obese C57B6/J mice with a potential to provide cardio protective benefits
por: Anil, Tharappel M, et al.
Publicado: (2014)

CNX-012-570, a direct AMPK activator provides strong glycemic and lipid control along with significant reduction in body weight; studies from both diet-induced obese mice and db/db mice models
por: Anil, Tharappel M, et al.
Publicado: (2014)

Fast food diet with CCl4 micro-dose induced hepatic-fibrosis –a novel animal model
por: Chheda, Tarak K, et al.
Publicado: (2014)

Glucolipotoxicity in Pancreatic β-Cells
por: Kim, Ji-Won, et al.
Publicado: (2011)

Cardiac Glucolipotoxicity and Cardiovascular Outcomes
por: Cerf, Marlon E.
Publicado: (2018)

Glucolipotoxicity and GLP-1 secretion
por: Hong, Jung-Hee, et al.
Publicado: (2021)

Human Pancreatic Islets React to Glucolipotoxicity by Secreting Pyruvate and Citrate
por: Perrier, Johan, et al.
Publicado: (2023)

FGF-23 protects cell function and viability in murine pancreatic islets challenged by glucolipotoxicity
por: Pajaziti, Betina, et al.
Publicado: (2022)

Sphingolipid Metabolic Pathway: An Overview of Major Roles Played in Human Diseases
por: Pralhada Rao, Raghavendra, et al.
Publicado: (2013)

Par-4/NF-κB Mediates the Apoptosis of Islet β Cells Induced by Glucolipotoxicity
por: QiNan, Wu, et al.
Publicado: (2016)

Developmental Programming and Glucolipotoxicity: Insights on Beta Cell Inflammation and Diabetes
por: Cerf, Marlon E.
Publicado: (2020)

Targeting ferroptosis suppresses osteocyte glucolipotoxicity and alleviates diabetic osteoporosis
por: Yang, Yiqi, et al.
Publicado: (2022)

The Higher Plasma Malondialdehyde Concentrations Are Determined by Metabolic Syndrome-Related Glucolipotoxicity
por: Moreto, Fernando, et al.
Publicado: (2014)

JNK1 Protects against Glucolipotoxicity-Mediated Beta-Cell Apoptosis
por: Prause, Michala, et al.
Publicado: (2014)

Mesenchymal Stem Cells Ameliorated Glucolipotoxicity in HUVECs through TSG-6
por: An, Xingxing, et al.
Publicado: (2016)

Stigmasterol prevents glucolipotoxicity induced defects in glucose-stimulated insulin secretion
por: Ward, Meliza G., et al.
Publicado: (2017)

Activation of Aldehyde Dehydrogenase 2 Ameliorates Glucolipotoxicity of Pancreatic Beta Cells
por: Chen, Shiau-Mei, et al.
Publicado: (2021)

Phenotypic Screening for Small Molecules that Protect β-Cells from Glucolipotoxicity
por: Small, Jonnell C., et al.
Publicado: (2022)

Carnosine scavenging of glucolipotoxic free radicals enhances insulin secretion and glucose uptake
por: Cripps, Michael J., et al.
Publicado: (2017)

Age and Sex Influence Mitochondria and Cardiac Health in Offspring Exposed to Maternal Glucolipotoxicity
por: Louwagie, Eli J., et al.
Publicado: (2020)

Glucolipotoxicity induces endothelial cell dysfunction by activating autophagy and inhibiting autophagic flow
por: Liu, Yulan, et al.
Publicado: (2022)

Liraglutide Attenuates Glucolipotoxicity-Induced RSC96 Schwann Cells’ Inflammation and Dysfunction
por: Kornelius, Edy, et al.
Publicado: (2022)

Guards and Culprits in the Endoplasmic Reticulum: Glucolipotoxicity and β-Cell Failure in Type II Diabetes
por: Karunakaran, Udayakumar, et al.
Publicado: (2012)

Accelerated renal disease is associated with the development of metabolic syndrome in a glucolipotoxic mouse model
por: Martínez-García, Cristina, et al.
Publicado: (2012)

P38 Plays an Important Role in Glucolipotoxicity-Induced Apoptosis in INS-1 Cells
por: Zhou, Lingli, et al.
Publicado: (2014)

Glucolipotoxicity: A Proposed Etiology for Wooden Breast and Related Myopathies in Commercial Broiler Chickens
por: Lake, Juniper A., et al.
Publicado: (2020)

Gut Metabolite Trimethylamine N-Oxide Protects INS-1 β-Cell and Rat Islet Function under Diabetic Glucolipotoxic Conditions
por: Krueger, Emily S., et al.
Publicado: (2021)

Overexpression of Insig-1 protects β cell against glucolipotoxicity via SREBP-1c
por: Chen, Ke, et al.
Publicado: (2011)

The Effects of Glyburide on Apoptosis and Endoplasmic Reticulum Stress in INS-1 Cells in a Glucolipotoxic Condition
por: Kwon, Min Jeong, et al.
Publicado: (2011)

Accumulation of 3-hydroxytetradecenoic acid: Cause or corollary of glucolipotoxic impairment of pancreatic β-cell bioenergetics?
por: Doliba, Nicolai M., et al.
Publicado: (2015)

Enhancer of Zeste Homolog 2 (EZH2) Mediates Glucolipotoxicity-Induced Apoptosis in β-Cells
por: Dahlby, Tina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f3ut8ckij4n3so6avft9mjomhb